ArticleJournal of building engineering2022
Prediction of respiratory droplets evolution for safer academic facilities planning amid COVID-19 and future pandemics: A numerical approach.
Article in Journal of building engineering, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed.
- The Selective Detection of Individual Respiratory Droplets in Air.ACS sensors · 2026Article
- Experimental study on bioaerosols behavior and purification measures in a subway compartment.Scientific reports · 2024Article
- A model for SARS-CoV-2 virus transmission on the upper deck of a passenger ship bound for a short trip.Heliyon · 2024Article
- Numerical performance of COScientific reports · 2024Article
- Virus-laden droplet nuclei in vortical structures associated with recirculation zones in indoor environments: A possible airborne transmission of SARS-CoV-2.Environmental advances · 2023Review
- Investigation on the cross-infection control performance of interactive cascade ventilation in multi-scenario of winter.Journal of building engineering · 2023Article
- Influences of obstacle factors on the transmission trends of respiratory infectious diseases in indoor public places.Journal of building engineering · 2023Article
- A review on indoor airborne transmission of COVID-19- modelling and mitigation approaches.Journal of building engineering · 2023Review
- Mechanisms controlling the transport and evaporation of human exhaled respiratory droplets containing the severe acute respiratory syndrome coronavirus: a review.Environmental chemistry letters · 2023Review
- Analysis on the thermal performance of low-temperature radiant floor coupled with intermittent stratum ventilation (LTR-ISV) for space heating.Energy and buildings · 2023Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Airborne dispersion of the novel SARS-CoV-2 through the droplets produced during expiratory activities is one of the main transmission mechanisms of this virus from one person to another. Understanding how these droplets spread when infected humans with COVID-19 or other airborne infectious diseases breathe, cough or sneeze is essential for improving prevention strategies in academic facilities. This work aims to assess the transport and fate of droplets in indoor environments using Computational Fluid Dynamics (CFD). This study employs unsteady Reynolds-Averaged Navier-Stokes (URANS) simulations with the Euler-Lagrange approach to visualize the location of thousands of droplets released in a respiratory event and their size evolution. Furthermore, we assess the dispersion of coughing, sneezing, and breathing saliva droplets from an infected source in a classroom with air conditioning and multiple occupants. The results indicate that the suggested social distancing protocol is not enough to avoid the transmission of COVID-19 since small saliva droplets ( ≤ 12
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.